THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT


Soysal T., Eskazan A. E. , Sadri S., Erdogan I., Berk S., Yalniz F. F. , ...More

20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.447 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 100
  • City: Vienna
  • Country: Austria
  • Page Numbers: pp.447